1. Home
  2. EBON vs MDXH Comparison

EBON vs MDXH Comparison

Compare EBON & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$1.60

Market Cap

16.0M

Sector

Technology

ML Signal

N/A

Logo MDxHealth SA

MDXH

MDxHealth SA

N/A

Current Price

$0.15

Market Cap

15.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EBON
MDXH
Founded
2010
2003
Country
United States
Belgium
Employees
N/A
364
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
15.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EBON
MDXH
Price
$1.60
$0.15
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
★ $0.83
AVG Volume (30 Days)
7.7K
★ 1.7M
Earning Date
08-14-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.81
Revenue Next Year
N/A
$13.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.15
52 Week High
$4.49
$4.63

Technical Indicators

Market Signals
Indicator
EBON
MDXH
Relative Strength Index (RSI) 37.46 22.87
Support Level N/A N/A
Resistance Level $2.32 $0.64
Average True Range (ATR) 0.15 0.02
MACD -0.03 0.00
Stochastic Oscillator 31.77 9.87

Price Performance

Historical Comparison
EBON
MDXH

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: